10/29/2025Abbisko Presents Promising Preclinical Data on Novel CDK4/2 Inhibitor ...

10/29/2025NMPA Approves Huadong Pharma's Mifanertinib Maleate for EGFR-Mutant NS...

10/29/2025Immunofoco Raises Series B+ Funding to Advance CAR-T Platforms for Sol...

10/29/2025Pharmaron to Acquire Biortus in China

10/29/2025NHSA Launches Public Consultation Module for DRG Payment Grouping Plan...

10/29/2025China Issues Guidelines to Strengthen Primary Care Chronic Disease Man...

10/28/2025Innovent's Mazdutide Tops Ozempic in Phase III Diabetes and Obesity Tr...

10/28/2025Metis TechBio to File China NDA for AI-Designed PBA Drug MTS-004

10/28/2025Over 400 Companies Join China's 11th Round of VBP

10/27/2025Lanma's LM103 TIL Therapy Moves Into Phase 2 After Promising Phase 1 D...

10/27/2025Alphamab Doses First Patient in Phase 1 Trial of PD-L1/αvβ6 Bispecif...

10/27/2025Zai Lab Shares Phase 1 Data for DLL3-Targeted ADC Rivaling Amgen's Imd...

10/27/2025AstraZeneca Unveils Three Major Initiatives in China

10/25/2025Recent Executive Moves

10/24/2025Boehringer Ingelheim's Jascayd Wins NMPA Approval for IPF

10/24/2025METiS's AI-Designed MTS-004 Becomes China's First AI-Enabled Formulati...

10/24/2025Chinese Biotech Launches Genos, an Advanced Human-Centric Genomic AI M...

10/22/2025Samsung Bioepis and Phrontline Forge Partnership to Co-Develop Next-Ge...

10/22/2025China's Aging Population to Drive Trillion-Dollar Healthcare Boom, UBS...

10/22/2025Multitude Reports Strong Efficacy for CD44v9-Targeted ADC AMT-116 at E...

10/22/2025Zai Lab Launches First Phase 3 Trial of DLL3-Targeted ADC ZL-1310 in R...

10/22/2025Understanding China's Longevity Market: Industry Segments, Trends and ...

10/21/2025ESMO 2025 Highlights China's Strategic Leap in Oncology Innovation

10/21/2025Merck KGaA and Abbisko Report Strong Phase 3 Results for Pimicotinib a...

10/21/2025RemeGen's Disitamab Vedotin Plus Toripalimab Delivers Breakthru First-...

10/21/2025Sunnovo Invests in Byterna to Advance Circular mRNA

10/21/2025Kelun-Biotech’s Sacituzumab Tirumotecan Shows Strong Phase 3 Results

10/20/2025Akeso Reports Strong China Data for Ivonescimab in Lung Cancer

10/20/2025Sanofi Launches €1B Insulin API Manufacturing Project in Beijing

10/20/2025CDE Seeks Comments on Implementation Recommendations and Chinese Tran...

Page:1/370 Total number of articles:11079: [First][<<] [1] [2] [3] [4] [5] [>>] [End]